MOTS-c has broader metabolic effects
Its not a normal situation that a blockbuster drug immediately goes on shortage and meets criteria for compounding pharmacies to compound it, said Tenille Davis, an Arizona pharmacist and the chief advocacy officer for the Alliance of Pharmacy Compounding, an industry group representing compounding pharmacists
We develop product candidates internally and through licensing collaborations, partnerships and joint ventures
Papp & Papp in Salzburg, Austria
And still others have both early and late symptoms
Results Here, we report the first orally administered, pH-responsive liposomal formulation of the HS donor GYY4137, specifically designed for colon-targeted delivery